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Background: Central Sleep Apnea (CSA) is often present in patients with chronic heart failure (CHF) and is associated with increased mortality. 
Phrenic nerve stimulation can be used to modulate diaphragmatic contraction and affect breathing. We hypothesized that stimulation of the phrenic 
nerve during a central event could be used to initiate inspiration or increase inspiratory time, halting or preventing the apnea.
Methods: 14 patients (mean EF = 42.2 %, NYHA II = 57 %) underwent implantation of a LassoTM catheter into the right brachiocephalic vein or 
superior vena cava. Four initial patients underwent implantation to evaluate the proof of concept. Ten additional subjects were studied to determine 
the effect of stimulation on CSA . The placement of the Lasso could not be maintained in four patients. Phrenic nerve stimulation was performed 
during periods of CSA at low current levels (<10mA) in the 6 subjects with stable Lasso placement.
Results: In the 10 subjects studied, the ability to stimulate the phrenic nerve transvenously was demonstrated and was tolerated while sleeping 
without safety issues. In the 6 patients that underwent stimulation during central events there was an improvement in CSA. A normal breathing 
pattern was restored and/or there was an improvement in oxygenation.
Conclusions: Phrenic nerve stimulation is able to safely break periods of central apnea during sleep and restore normal breathing patterns in 
patients with CHF and CSA. This approach may represent a novel treatment for CSA.
